PortfoliosLab logoPortfoliosLab logo
MED vs. FF
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

MED vs. FF - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Medifast, Inc. (MED) and FutureFuel Corp. (FF). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, MED achieves a 11.33% return, which is significantly lower than FF's 46.58% return. Over the past 10 years, MED has underperformed FF with an annualized return of -7.29%, while FF has yielded a comparatively higher 3.98% annualized return.


MED

1D
-0.25%
1M
-4.73%
YTD
11.33%
6M
-3.80%
1Y
-8.40%
3Y*
-46.74%
5Y*
-45.89%
10Y*
-7.29%

FF

1D
0.88%
1M
14.41%
YTD
46.58%
6M
38.76%
1Y
16.71%
3Y*
-6.25%
5Y*
-4.53%
10Y*
3.98%
*Multi-year figures are annualized to reflect compound growth (CAGR)

MED vs. FF - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
MED
Medifast, Inc.
11.33%-39.39%-73.79%-38.34%-42.31%9.36%86.18%-9.73%82.11%72.33%
FF
FutureFuel Corp.
46.58%-35.84%31.03%-22.78%9.85%-26.86%37.61%-20.32%14.46%3.12%

Correlation

The correlation between MED and FF is 0.12, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.12

Correlation (3Y)
Calculated over the trailing 3-year period

0.14

Correlation (5Y)
Calculated over the trailing 5-year period

0.22

Correlation (10Y)
Calculated over the trailing 10-year period

0.26

Correlation (All Time)
Calculated using the full available price history since Mar 23, 2011

0.28

The correlation between MED and FF shifts across timeframes, from 0.12 (1 year) to 0.28 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

MED:

$130.86M

FF:

$202.52M

EPS

MED:

-$1.82

FF:

-$1.19

PS Ratio

MED:

0.38

FF:

1.83

PB Ratio

MED:

0.66

FF:

1.43

Total Revenue (TTM)

MED:

$346.10M

FF:

$110.11M

Gross Profit (TTM)

MED:

$242.70M

FF:

-$26.13M

EBITDA (TTM)

MED:

-$3.86M

FF:

-$50.17M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

MED vs. FF — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MED
MED Risk / Return Rank: 3333
Overall Rank
MED Sharpe Ratio Rank: 3333
Sharpe Ratio Rank
MED Sortino Ratio Rank: 3030
Sortino Ratio Rank
MED Omega Ratio Rank: 3131
Omega Ratio Rank
MED Calmar Ratio Rank: 3535
Calmar Ratio Rank
MED Martin Ratio Rank: 3535
Martin Ratio Rank

FF
FF Risk / Return Rank: 5959
Overall Rank
FF Sharpe Ratio Rank: 6060
Sharpe Ratio Rank
FF Sortino Ratio Rank: 5656
Sortino Ratio Rank
FF Omega Ratio Rank: 5757
Omega Ratio Rank
FF Calmar Ratio Rank: 6060
Calmar Ratio Rank
FF Martin Ratio Rank: 6060
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

MED vs. FF - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Medifast, Inc. (MED) and FutureFuel Corp. (FF). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


MEDFFDifference
Sharpe ratioReturn per unit of total volatility

-0.73

Sortino ratioReturn per unit of downside risk

-1.08

Omega ratioGain probability vs. loss probability

0.99

1.14

-0.14

Calmar ratioReturn relative to maximum drawdown

-0.26

0.81

-1.07

Martin ratioReturn relative to average drawdown

-0.44

1.67

-2.12

MED vs. FF - Sharpe Ratio Comparison

The current MED Sharpe Ratio is -0.23, which is lower than the FF Sharpe Ratio of 0.50. The chart below compares the historical Sharpe Ratios of MED and FF, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

MED vs. FF - Drawdown Comparison

The maximum MED drawdown since its inception was -98.40%, which is greater than FF's maximum drawdown of -64.23%. Use the drawdown chart below to compare losses from any high point for MED and FF.


Loading charts...

Drawdown Indicators


MEDFFDifference

Max Drawdown

Largest peak-to-trough decline

-98.40%

-64.23%

-34.17%

Max Drawdown (1Y)

Largest decline over 1 year

-37.39%

-30.85%

-6.54%

Max Drawdown (3Y)

Largest decline over 3 years

-90.91%

-51.46%

-39.45%

Max Drawdown (5Y)

Largest decline over 5 years

-96.29%

-51.46%

-44.83%

Max Drawdown (10Y)

Largest decline over 10 years

-96.76%

-64.23%

-32.53%

Current Drawdown

Current decline from peak

-95.96%

-45.08%

-50.88%

Average Drawdown

Average peak-to-trough decline

-50.84%

-30.54%

-20.30%

Ulcer Index

Depth and duration of drawdowns from previous peaks

21.83%

14.89%

+6.94%

Volatility

MED vs. FF - Volatility Comparison

Medifast, Inc. (MED) and FutureFuel Corp. (FF) have volatilities of 8.94% and 9.35%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


MEDFFDifference

Volatility (1M)

Calculated over the trailing 1-month period

8.94%

9.35%

-0.41%

Volatility (6M)

Calculated over the trailing 6-month period

31.69%

39.19%

-7.50%

Volatility (1Y)

Calculated over the trailing 1-year period

41.90%

49.93%

-8.03%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

45.25%

46.27%

-1.02%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

47.68%

44.61%

+3.07%

Dividends

MED vs. FF - Dividend Comparison

MED has not paid dividends to shareholders, while FF's dividend yield for the trailing twelve months is around 4.13%.


PositionTTM20252024202320222021202020192018201720162015
FF
FutureFuel Corp.
4.13%7.52%51.80%3.95%2.95%35.86%25.51%1.94%1.51%1.70%18.20%1.78%
MED
Medifast, Inc.
0.00%0.00%0.00%7.36%5.69%2.71%2.30%3.08%1.75%2.06%2.57%0.82%

Financials

MED vs. FF - Financials Comparison

This section allows you to compare key financial metrics between Medifast, Inc. and FutureFuel Corp.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00100.00M200.00M300.00M400.00M500.00M20222023202420252026
76.04M
31.90M
(MED) Total Revenue
(FF) Total Revenue
Values in USD except per share items

MED vs. FF - Profitability Comparison

The chart below illustrates the profitability comparison between Medifast, Inc. and FutureFuel Corp. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

-100.0%-50.0%0.0%50.0%20222023202420252026
68.1%
0
Portfolio components
MED - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Medifast, Inc. reported a gross profit of 51.76M and revenue of 76.04M. Therefore, the gross margin over that period was 68.1%.

FF - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, FutureFuel Corp. reported a gross profit of 0.00 and revenue of 31.90M. Therefore, the gross margin over that period was 0.0%.

MED - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Medifast, Inc. reported an operating income of -3.30M and revenue of 76.04M, resulting in an operating margin of -4.3%.

FF - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, FutureFuel Corp. reported an operating income of -20.84M and revenue of 31.90M, resulting in an operating margin of -65.3%.

MED - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Medifast, Inc. reported a net income of -2.12M and revenue of 76.04M, resulting in a net margin of -2.8%.

FF - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, FutureFuel Corp. reported a net income of -20.58M and revenue of 31.90M, resulting in a net margin of -64.5%.


Frequently Asked Questions


MED and FF have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

FF has higher volatility (9.35%) compared to MED (8.94%). In terms of maximum drawdown, MED dropped -98.40% vs FF's -64.23%.

FF currently has the higher Sharpe Ratio (0.50 vs -0.23), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for MED and FF

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer